Table 1:
Baseline characteristics of black and white patients from the SEER (Surveillance, Epidemiology, and End Results) database with hepatocellular cancer (2005–2015) as identified from the 100 most populous counties from the United States Census (2010)
| All (N= 37,853) |
Black (N=6,740) |
White (N=31,113) |
P-Value | |
|---|---|---|---|---|
| Individual Characteristics | ||||
| Age at diagnosis, mean ± SD | 62.7 ±12.0 | 60.7 ±9.6 | 63.2 ± 12.4 | <0.001 |
| Female, N (%) | 8,285 (21.9) | 1,487 (22.1) | 6,798 (21.9) | 0.70 |
| Region, N (%) | <0.001 | |||
| Northeast | 6,169 (16.3) | 1,069 (15.9) | 5,100 (16.4) | |
| South | 4,751 (12.6) | 2,069 (30.7) | 2,682 (8.6) | |
| Midwest | 2,864 (7.6) | 1,051 (15.6) | 1,813 (5.8) | |
| West | 24,069 (63.6) | 2,551 (37.9) | 21,518 (69.2) | |
| Stage at Diagnosis, N (%) | <0.001 | |||
| Stage I | 11,932 (31.5) | 1,973 (29.3) | 9,959 (32.0) | |
| Stage II | 6,430 (17.0) | 1,026 (15.2) | 5,404 (17.4) | |
| Stage III | 7,360 (19.4) | 1,537 (22.8) | 5,823 (18.7) | |
| Stage IV | 5,379 (14.2) | 1,106 (16.4) | 4,273 (13.7) | |
| Unknown | 6,752 (17.8) | 1098 (16.3) | 5,654 (18.2) | |
| Surgery, N (%) | 8,458 (22.3) | 1,331 (19.8) | 7,127 (22.9) | <0.001 |
| Index of Dissimilarity, mean ± SD | 0.61 ± 0.08 | 0.67 ± 0.10 | 0.60 ± 0.07 | <0.001 |